Information & Publications | Bio & Resume



Articles:

Regular postings at Medical Progress Today, Charles L. Hooper, The Manhattan Institute
View Article>>

Predicting Our Demise from Hoover Institution Defining Ideas, Charles L. Hooper, October 7, 2011
View Article>>

The Cost of Prescription Drugs is Appropriate The Pharmaceutical Industry, Opposing Viewpoints Series, October 2011, Greenhaven Press.

The FDA's War on Drugs from Hoover Institution Defining Ideas, Charles L. Hooper and David R. Henderson, July 27, 2011
View Article>>

The Federal Government Bares Its Teeth At A Pharma CEO from Forbes.com by Charles L. Hooper and David R. Henderson, May 5, 2011
View Article>>

Mercantilism Lives
from Library of Economics and Liberty by Charles L. Hooper, April 4, 2011
View Article>>

We Smell a Rat: Tests in rats
shouldn't kill a promising new drug for RLS
from Medical Progress Today by Charles L. Hooper and David R. Henderson, March 2010
View Article>>

The Soviet Unionization of Health Care from The Future of Freedom Foundation by Charles L. Hooper and David R. Henderson, March 2010
View Article>>

Pfizer's $2.3 Billion-Dollar Settlement from Forbes.com by Charles L. Hooper and David R. Henderson, September 2009
View Article>>

Markets Can Determine Drug Efficacy from Forbes.com by Charles L. Hooper and David R. Henderson, July 2009
View Article>>

The FDA's Big Bad Wolf from Forbes.com by Charles L. Hooper and David R. Henderson, January 2009
View Article>>

Obama And The 'Drug Killer'
from Forbes.com by Charles L. Hooper, October 31, 2008
View Article>>

Swing Vote at the FDA
from Medical Progress Today by Charles L. Hooper and David R. Henderson, August 29th, 2008.
Download pdf >>

FDA Walls Do Not Encircle
by Charles L. Hooper, The Library of Economics and Liberty, July 7, 2008.
Download pdf >>

Pharmaceuticals: Economics and Regulation, The Concise Encyclopedia of Economics, edited by David R. Henderson, Liberty Fund, Indianapolis, 2008, pg 388-392
The Concise Library of Economics >>

OTC Mevacor Goes Down for the Third Time -
by David R. Henderson and Charles L. Hooper, Medical Progress Today, March 1, 2008
Medical Progress Today website >>

Other voices: Does the Iraq war protect you?" The Union, October 18, 2007.
Download pdf >>

Is Cal Thomas Right or Wrong?"LewRockwell.com, September 20, 2007
download pdf >>

Our Lawless FDA
by David R. Henderson and Charles L. Hooper, Wall Strett Journal, May 17, 2007
Download pdf >>

Confessions of a Drug Killer by Charles L. Hooper, Tech Central Station, May 8, 2007
TCS Daily website >>

When Lady Luck Plays Moneyball by David R. Henderson and Charles L. Hooper, Tech Central Station, October 20, 2006
Download pdf >>
TCS Daily website >>

The FDA's Marijuana Problem by Charles L. Hooper, Tech Central Station, August 18, 2006
Download pdf >>
TCS Daily website >>

GM/UAW Driving Healthcare in Wrong Direction by David R. Henderson and Charley Hooper, Lew Rockwell, September 5, 2005
view >>

Clear Thinking About Vioxx by David R. Henderson and Charley Hooper, Reason Magazine Online, January 3, 2005
Download pdf

Grey Matter by David R. Henderson and Charley Hooper, Tech Central Station, November 19, 2004
Download pdf

The Myth of the Wasted Vote by Charles L. Hooper, Lew Rockwell, September 21, 2004.
view >>

The Top One Percent Includes You by David R. Henderson and Charley Hooper, Tech Central Station, May 20, 2004
Download pdf

The Social Security Trust Fund is Irrelevant (Or How Al Gore Was Right), with David R. Henderson, Tech Central Station, May 4, 2005.
Download pdf

Hidden Drug-reimport Potential by David R. Henderson and Charley Hooper, The Washington Times, February 24, 2004
Download pdf

Charles' biography of Henry George, the printer-journalist, political economist, and reformer who was an important and influential radical theorist of nineteenth century America.
view >>

Charles L. Hooper is President and co-founder of Objective Insights, Inc., a health care consulting company. Objective Insights helps health care companies make multi-million to billion dollar decisions regarding their business opportunities. He is also a visiting fellow at the Hoover Institution at Stanford University.


Work Experience:

Visiting Fellow, The Hoover Institution, Stanford University

President and Co-Founder, Objective Insights, Inc.
• Successfully completed over 270 projects for 50 clients in the pharmaceutical, biotechnology, diagnostic, and device fields.
• Areas of expertise include: sales forecasting, decision analysis, product pricing, public policy analysis, market research, portfolio analysis and optimization, and business development.

Senior Market Research Analyst, Syntex Labs
• Responsible for product pricing, sales forecasting, decision analysis, business development deal analysis, and probabilistic simulation.

Marketing Analyst, Merck and Co.
• Responsible for product pricing, sales forecasting, decision analysis, probabilistic simulation, financial analysis, and systems management.

President and Co-Founder, Highway 9 Design
• Holds a U.S. Patent on a product that he and his brother invented and marketed.
• Performed all functions required by a small start-up automotive product company.

Scientific Applications Programmer, NASA/Ames Research Center
• Chief programmer for ten Ph.D. researchers conducting small-scale fluid mechanics experiments.
• Provided data acquisition and analysis software and support.

Education:

M.S. in Engineering-Economics Systems (management science, decision analysis, public policy analysis, and economics) from Stanford University.
• Research project: Pricing and economic analysis of the California State Water Project.

CATO Institute, Seminar in political economy at Dartmouth College, Hanover, NH.

B.S. in Computer Science Engineering from Santa Clara University.
• Summer session in economics and liberal arts at University of Durham, Durham, England.
• Thesis topic: Economic comparison of different decentralized traffic light control algorithms (one original and two existing) using a computer simulation.

Publications:       

Regular postings at Medical Progress Today, Charles L. Hooper, The Manhattan Institute
• Predicting Our Demise from Hoover Institution Defining Ideas, Charles L. Hooper, October 7, 2011
• The Cost of Prescription Drugs is Appropriate The Pharmaceutical Industry, Opposing Viewpoints Series, October 2011, Greenhaven Press.
• The FDA's War on Drugs from Hoover Institution Defining Ideas, Charles L. Hooper and David R. Henderson, July 27, 2011
The Federal Government Bares Its Teeth At A Pharma CEO from Forbes.com by Charles L. Hooper and David R. Henderson, May 5, 2011
Mercantilism Lives from Library of Economics and Liberty by Charles L. Hooper, April 4, 2011
• We Smell a Rat: Tests in rats shouldn't kill a promising new drug for RLS from Medical Progress Today by Charles L. Hooper and David R. Henderson, March 2010
• The Soviet Unionization of Health Care
from The Future of Freedom Foundation by Charles L. Hooper and David R. Henderson, March 2010
• Pfizer's $2.3 Billion-Dollar Settlement
from Forbes.com by Charles L. Hooper and David R. Henderson, September 2009
• Markets Can Determine Drug Efficacy
from Forbes.com by Charles L. Hooper and David R. Henderson, July 2009
• The FDA's Big Bad Wolf
from Forbes.com by Charles L. Hooper and David R. Henderson, Jan. 2009
• Obama And The 'Drug Killer'
from Forbes.com by Charles L. Hooper, October 31, 2008.
• Swing Vote at the FDA
from Medical Progress Today, August 29th, 2008.
• FDA Walls Do Not Encircle
The Library of Economics and Liberty, July 7, 2008.
• Pharmaceuticals: Economics and Regulation," The Concise Encyclopedia of Economics,
edited by David R. Henderson, Liberty Fund, Indianapolis, 2008, pg 388-392
• OTC Mevacor Goes Down for the Third Time - But it's the FDA that deserves a thumbs down
by David R. Henderson and Charles L. Hooper, Medical Progress Today, March 1, 2008
• Other voices: Does the Iraq war protect you?
The Union, October 18, 2007.
• Is Cal Thomas Right or Wrong?
LewRockwell.com, September 20, 2007
• Our Lawless FDA
by David R. Henderson and Charles L. Hooper, Wall Strett Journal, May 17, 2007
• Confessions of a Drug Killer
by Charles L. Hooper, Tech Central Station, May 8, 2007
• When Lady Luck Plays Moneyball,
Tech Central Station, October 2006
• FDA's Marijuana Problem,
Tech Central Station, August 2006
Making Great Decisions in Business and Life, with coauthor David R. Henderson. (www.MakingGreatDecisions.com)
• GM/UAW Driving Healthcare in Wrong Direction, Lew Rockwell, September 5, 2005
Clear Thinking About Vioxx, with David R. Henderson, Reason Magazine Online, January 3, 2005
• Grey Matter by David R. Henderson and Charley Hooper, Tech Central Station, November 19, 2004
The Myth of the Wasted Vote, Lew Rockwell, September 21, 2004.
The Top One Percent Includes You, Tech Central Station, May 20, 2004.
• The Social Security Trust Fund is Irrelevant (Or How Al Gore Was Right), with David R. Henderson, Tech Central Station, May 4, 2005.
Hidden Drug-Reimport Potential, The Washington Times, February 2004.
Decide to Profit, BioFinance, Ernst & Young LLP, June 1995.
Biography of Henry George, The Fortune Encyclopedia of Economics, David R. Henderson editor, 1993.
Pricing and promotion, Scrip Magazine Letters section, October 1992.
Hybrid Approach to Data Reduction for Multi-Sensor Hot Wires, Experiments in Fluids; (11, 1991).
Numerous letters to the editors of various newspapers

Public Speaking:

• Energizer Holdings, “Making Great Decisions in Business and Life,” April 7, 2011, St. Louis, Missouri
• Center for Competitive Management web-based conference, “Great Decision-Making: Essential Skills to Make Wise Management Decisions,” November 5, 2010
• Making Great Decisions, Speakers: David Henderson and Charles Hooper, Google, September 2007, Mountain View, CA - YouTube Video >>
• Pharmaceuticals: Regulation and Economics, Naval Postgraduate School, March 2007, Monterey, CA
• Deal Valuation Techniques, BIO 2003 Meeting, June 2003, Washington, D.C.
• Pharmaceuticals and The FDA, January 2003, Nevada City, California
• Develop Long-Term Market Forecasts as Input to the Portfolio Management Process. Pharmaceutical Portfolio Optimization (CBI), October 2002, Philadelphia, Pennsylvania.
• Pharmaceutical and Biotech Product Pricing. WBBA Breakfast Series, January 1999, Seattle, Washington.
• Decision-Based Management [Quantifying Risk to Aid Decisions], BIO 1997 Meeting, June 1997, Houston, Texas.
• Should the Cure for Cancer Cost the Same in California and Calcutta?, IBC International Pharmaceutical Pricing Congress, February 1995, New Orleans, Louisiana.
• Insights Into Pricing: An Important Problem Child, IBC Pharmaceutical Pricing Conference, June 1994, Philadelphia, Pennsylvania.

Task Force Membership:

• Syntex Labs' Strategic Planning task force in 1994.
• Merck's Pricing 2000 task force in 1991.

  Back to the Charles L. Hooper homepage


© Copyright 2011 Charles L. Hooper